BCRXBioCryst Pharmaceuticals, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $9.02 (+0.00% today)

Market Cap: $1.89B

P/E (TTM): 7.20

Forward P/E (FY1): 32.80

EPS Growth: 71.9%

Relative Strength (RS%): 1

-20.2% from 52-week high

Back to Scanner

BCRX

NASDAQRS 1Score 34

BioCryst Pharmaceuticals, Inc.

HealthcareBiotechnology$1.89B1 setup passing
$9.02
0.0% ($0.00)
-20.2% from 52W High
P/E (TTM)
7.20
Fwd P/E
32.80
PEG
Analyst Upside
EPS Growth
71.9%
Gross Margin
97.7%
ROE
-76.5%
D/E
-4.01
Div Yield
0.0%
Avg Volume
7.8M

Price Chart

Key Levels

SMA 200
$7.88
SMA 50
$7.93
Price
$9.02
52W High
$11.30

Setup Radar

1/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst